Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to α-interferon therapy

Cancer

Volumn 77, Issue 12, 1996, Pages 2604-2613

  Mazzaro, Cesare ^a   Franzin, Francesco ^b   Tulissi, Patrizia ^c   Pussini, Elisabetta ^c   Crovatto, Marina ^a   Carniello, Giorgio S ^a   Efremov, Dimitar G ^b   Burrone, Oscar ^b   Santini, Gianfranco ^a   Pozzato, Gabriele ^c,d  

^a Pordenone General Hospital   (Italy)

^b Intl Ctr Genetic Eng and Biotech   (Italy)

^c UNIVERSITY OF TRIESTE   (Italy)

^d UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Hepatitis C virus; Mixed cryoglobulinemia; Non Hodgkin's lymphoma; Viral diversity; interferon

Indexed keywords

ALPHA INTERFERON;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; BONE MARROW BIOPSY; CONTROLLED STUDY; CRYOGLOBULINEMIA; DRUG RESPONSE; FEMALE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; LYMPHOCYTE CLONE; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; B-LYMPHOCYTES; BASE SEQUENCE; CLONE CELLS; CRYOGLOBULINEMIA; DNA PRIMERS; FEMALE; GENE REARRANGEMENT, B-LYMPHOCYTE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; INTERFERON TYPE I, RECOMBINANT; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; RNA, VIRAL;

EID: 0029941192     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960615)77:12<2604::AID-CNCR26>3.0.CO;2-V     Document Type: Article

References (41)

1. Grey HM, Kohler PF. Cryoglobulins. Semin Hematol 1973; 10:87-96.
2. Johnson RJ, Gretch DR, Yamabe H, Hart J, Bacchi CE, Hartwell P, et al. Membranoproliferative glomerulo-nephritis associated with hepatitis C virus infection. N Engl J Med 1993;7:465-70.
3. Disdier P, Harl JR, Weiller PJ. Cryoglobulinemia and hepatic infection. Lancet 1991;338:1151-3.
4. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327:1490-5.
5. Ferri C, Greco F, Longobardo G, Palla P, Moretti A, Marzo E, et al. Association between hepatitis C virus and mixed cryoglobulinemia. Clin Exp Rheumatol 1991;9:621-4.
6. Pascual M, Perrin L, Giostra E, Schifferli JA. Hepatitis C virus in patients with cryoglobulinemia type II. J Infect Dis 1990; 162:569-70.
7. Zignego AL, Macchia D, Monti M, Thiers V, Mazzetti M, Foschi M, et al. Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol 1992;15:382-7.
8. Ferri C, Monti M, La Civita L, Longobardo G, Greco F, Pasero G, et al. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood 1993;82:3701-4.
9. Invernizzi F, Pioltelli P, Cattaneo R, Gavazzeni V, Borzini P, Monti G, et al. Long-term follow-up study in essential mixed cryoglobulinemia. Acta Haematol 1979;61:9-15.
10. Pozzato G, Mazzaro C, Crovatto M, Modolo ML, Ceselli S, Mazzi G, et al. Low-grade malignant lymphoma, hepatitis C virus infection and mixed cryoglobulinemia. Blood 1994; 84:3047-53.
11. Ferri C, Marzo E, Longobardo G, Lombardini F, La Civita L, Vanacore R, et al. Interferon in mixed cryoglobulinemia patients: a randomized crossover controlled trial. Blood 1993;81:1132-8.
12. Mazzaro C, Pozzato G, Crovatto M, Moretti M, Modolo ML, Mazzi G, et al. Long-term effects of alfa-interferon therapy in mixed cryoglobulinemia. Haematologica 1994;79:342-9.
13. Misiani R, Bellavita P, Fenili D, Vicari A, Marchesi D, Sironi PL, et al. Interferon alpha-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994; 330:751-6.
14. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992;73:673-9.
15. National Cancer Institute sponsored study of classification of non-Hodgkin's lymphomas. Summary and description of a working formulation for clinical usage: the non-Hodgkin's lymphoma pathological classification project. Cancer 1982; 49:2112-35.
16. Stein H, Tolksdorf G, Burkert M, Lennert K. Cytologic classification of non-Hodgkin's lymphomas based on morphology, cytochemistry, and immunology. In: Growler DG, editor. Advances in medical oncology, research and education. New York: Pergamon, 1979:141-55.
17. Hui PK, Feller AC, Lennert K. High-grade non-Hodgkin's lymphoma of B-cell type histopathoogy. Histopathology 1988;12:127-35.
18. Young IT. Proof without prejudice: use of the Kolmogorov-Smirnov test for the analysis of histograms from flow system and other sources. J Histochem Cytochem 1977;25:935-41.
19. Ault AK. Detection of small numbers of monoclonal B lymphocytes in the blood of patients with lymphoma. N Engl J Med 1979;300:1401-5.
20. Chomzynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
21. Efremov DG, Batista FD, Burrone OR. Molecular analysis of IgE heavy chain transcript expressed in vivo by peripheral blood lymphocytes from normal and atopic individuals. J Immunol 1993;151:2195-207.
22. Chemello L, Cavalletto D, Pontisso P, Bortolotti F, Donada C, Donadon V, et al. Patterns of antibodies to hepatitis C virus in patients with chronic Non-A, Non-B hepatitis and their relationship to viral replication and liver disease. Hepatology 1993;17:179-83.
23. Okamoto H, Okada S, Sugiyama Y, Yotsumoto S, Tanaka T, Yoshizawa H, et al. The 5′ terminal sequence of hepatitis C virus genome. Jpn J Exp Med 1990;60:167-9.
24. Bukh J, Purcell RH, Miller RH. Sequence analysis of the 5′ noncoding region of hepatitis C virus. Proc Natl Acad Sci USA 1992;89:4942-6.
25. Kaneko S, Unoura M, Kobayashi K, Kuno K, Murakami S, Hattori N. Detection of serum hepatitis C virus RNA [letter]. Lancet 1990;335:976.
26. Okamoto H, Tokita H, Sakamoto M, Horikita M, Iizuka H, Mishiro S. Characterization of the genomic sequence of the type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. J Gen Virol 1994;75:629-35.
27. Davis GL, Balart LA, Schiff ER, Lindasay K, Bodenheimer HC, Perillo RP, et al. Treatment of chronic hepatitis C with recombinant interferon alpha. A multicenter randomized controlled trial. N Engl J Med 1989;321:1501-6.
28. Pozzato G, Kaneko S, Moretti M, Croce LS, Franzin F, Unoura M, et al. Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease. J Med Virol 1994;43:291-6.
29. Okamoto H, Crovatto M, Pozzato G, Feray C, Brechot C, Mishiro S. Molecular and clinical characteristics of the hepatitis C virus genotype "2c" found in Italians in Italy and France. Int Hepatol Comm 1995;3:161-5.
30. Chebat J, Bessech P, Mory Y, Mallucci L, Michalevicz R, Revel M. IFN and 2′5′ oligo A synthetase in cell growth and in differentiation of hematopoietic cells. In: Friedman RM, Merigan T, Sreevalsan T, editors. Interferons as cell growth inhibitors and antitumor factors. New York: Alan Liss, 1986:351-89.
31. Perl A, Gorevic PD, Ryan DH, Condemi JJ, Ruszkowski RJ, Abraham GN. Clonal B cell expansion in patients with essential mixed cryoglobulinemia. Clin Exp Immunol 1989;76:54-9.
32. Harfast B, Huddlstone JR, Casali P, Merigan TC, Oldstone MBA. Interferon acts directly on human B lymphocytes to modulate immunoglobulins synthesis. J Immunol 1991; 127:2146-50.
33. Exley R, Nathan P, Walker L, Gordon J, Clemens MJ. Antiproliferative effects of interferons on Daudi Burkitt-lymphoma cells: induction of cell differentiation and loss of response to autocrine growth factors. Int J Cancer 1987;40:53-9.
34. Di Bisceglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J, et al. Recombinant interferon alpha therapy for hepatitis C. A randomized, double-blind, placebo-controlled trial. N Engl J Med 1989;321:1506-10.
35. Pozzato G, Moretti M, Crocè LS, Sasso F, Kaneko S, Unoura M, et al. Interferon therapy in chronic HCV hepatitis: evidence of different outcome with respect to different viral strains. J Med Virol 1995;45:445-50.
36. Houghton M, Weiner A, Han J, Kuo G, Choo QL. Molecular biology of the hepatitis C viruses. Implications for diagnosis, development and control of viral disease. Hepatology 1991;14:381-8.
37. Shiramizu B, Barriga F, Neequaye J, Jafri A, Dalla-Favera R, Neri A, et al. Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and Epstein-Barr virus association. Blood 1991;77:1516-26.
38. Rowe M. Epstein-Barr virus and lymphoid malignancy. In: Hoffbrand AV, Brenner M, editors. Recent advances in hematology. London: Churchill Livingstone, 1992;6:205-22.
39. Gallo RC. Human retroviruses: a decade of discovery and link with human disease. J Infect Dis 1991;164:277-89.
40. Wotherspoon AC, Hortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991;338:1175-6.
41. Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993;342:575-7.